Enlitic's AI software approved for commercialization in U.S., EU

By AuntMinnie.com staff writers

May 27, 2022 -- Artificial intelligence (AI) software developer Enlitic said that its Curie platform and the AI application within Curie, Curie|Endex, recently received approval for commercialization in the U.S. and European Union (EU).

Enlitic developer Curie as a platform for hosting multiple AI applications in a manner that enables their use by radiologists without disrupting workflow. Curie|Endex is designed to transform medical imaging data into a standardized nomenclature while enabling relevant clinical content to be connected across disparate IT systems in a hospital.

The company said the products demonstrate compliance to requirements by the U.S. Food and Drug Administration (FDA) and the EU Medical Device Regulations.


Copyright © 2022 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: